Quality of life and symptom treatment response in postmenopausal women with advanced breast cancer (ABC) receiving Fulvestrant after progression on prior antiestrogen therapy

被引：0
|
作者：
Kalyadina, S. [1 ]
Novik, A. [2 ]
Ionova, T. [1 ]
机构：
[1] Multinat Ctr Qual Life Res, St Petersburg, Russia
[2] Pirogov Natl Med Surg Ctr, Moscow, Russia
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70666-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [41] ECONOMIC EVALUATION OF FULVESTRANT 500MG FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER WHO HAVE PROGRESSED ON ENDOCRINE THERAPY
    Polanco, A. C.
    Salazar, A.
    Soto, H.
    Pizarro, M.
    VALUE IN HEALTH, 2014, 17 (03) : A87 - A87
  • [42] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from an expanded access programme
    Petruzelka, L.
    Zimovjanova, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 132 - 133
  • [43] Fulvestrant: a new, effective and well-tolerated secondline treatment option for postmenopausal women with advanced breast cancer
    Dodwell, D
    Vergote, I
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S237 - S237
  • [44] FULVESTRANT ('FASLODEX'): A NEW OPTION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Kleeberg, Ulrich R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3537 - 3537
  • [45] QUALITY OF LIFE OF POSTMENOPAUSAL WOMEN WITH BREAST CANCER TREATED WITH ADJUVANT ENDOCRINE THERAPY
    Bellizzi, Keith M.
    Taxel, Pamela
    Dibble, Kate E.
    Siembida, Elizabeth J.
    Pescatello, Linda S.
    Schifano, Elizabeth D.
    Guarneri, Samantha
    Tannenbaum, Susan H.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1896 - S1896
  • [46] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    Blancas, I.
    Fontanillas, M.
    Conde, V.
    Lao, J.
    Martinez, E.
    Sotelo, M. J.
    Jaen, A.
    Bayo, J. L.
    Carabantes, F.
    Illarramendi, J. J.
    Gordon, M. M.
    Cruz, J.
    Garcia-Palomo, A.
    Mendiola, C.
    Perez-Ruiz, E.
    Bofill, J. S.
    Baena-Canada, J. M.
    Janez, N. M.
    Esquerdo, G.
    Ruiz-Borrego, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07): : 862 - 869
  • [47] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    I. Blancas
    M. Fontanillas
    V. Conde
    J. Lao
    E. Martínez
    M. J. Sotelo
    A. Jaen
    J. L. Bayo
    F. Carabantes
    J. J. Illarramendi
    M. M. Gordon
    J. Cruz
    A. García-Palomo
    C. Mendiola
    E. Pérez-Ruiz
    J. S. Bofill
    J. M. Baena-Cañada
    N. M. Jáñez
    G. Esquerdo
    M. Ruiz-Borrego
    Clinical and Translational Oncology, 2018, 20 : 862 - 869
  • [48] EVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST-CANCER
    PRIESTMAN, TJ
    BAUM, M
    LANCET, 1976, 1 (7965): : 899 - 901
  • [49] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from a compassionate use program.
    Petruzelka, L
    Zimovjanova, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 59S - 59S
  • [50] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - updated results from an expanded access programme
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 171 - 171
12345